DarioHealth (DRIO) to Release Earnings on Thursday

DarioHealth (NASDAQ:DRIO) is anticipated to announce its earnings results before the market opens on Thursday, March 27th. Analysts expect the company to announce earnings of ($0.24) per share and revenue of $7.39 million for the quarter. Investors that are interested in participating in the company’s conference call can do so using this link.

DarioHealth Price Performance

DarioHealth stock opened at $0.72 on Thursday. DarioHealth has a 52 week low of $0.56 and a 52 week high of $1.93. The company’s 50 day moving average price is $0.69 and its two-hundred day moving average price is $0.81. The company has a quick ratio of 1.32, a current ratio of 1.57 and a debt-to-equity ratio of 0.35. The stock has a market cap of $29.93 million, a P/E ratio of -0.77 and a beta of 1.42.

Wall Street Analyst Weigh In

Several equities research analysts have recently issued reports on the stock. Stifel Nicolaus decreased their price target on shares of DarioHealth from $3.50 to $2.00 and set a “buy” rating for the company in a research note on Tuesday, March 11th. TD Cowen lowered shares of DarioHealth from a “buy” rating to a “hold” rating and reduced their price objective for the company from $2.00 to $1.00 in a research note on Wednesday, January 29th.

About DarioHealth

DarioHealth Corp. operates as a digital health company in the United States, Canada, the European Union, Australia, and New Zealand. Its digital therapeutics platform and suite of solutions deliver personalized and dynamic interventions driven by data analytics and one-on-one coaching for diabetes, hypertension, weight management, musculoskeletal pain, and behavioral health.